Development of hot-melt extrusion as a novel technique for the ...
Development of hot-melt extrusion as a novel technique for the ...
Development of hot-melt extrusion as a novel technique for the ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
CHAPTER 5: AN IN VIVO AND IN VITRO TASTE MASKING EVALUATION OFBITTER MELT EXTRUDED APIs1.0 IntroductionThe t<strong>as</strong>te <strong>of</strong> a pharmaceutical <strong>for</strong>mulation h<strong>as</strong> major influence on patient complianceto <strong>the</strong> medication and <strong>the</strong>re<strong>for</strong>e <strong>the</strong> t<strong>as</strong>te m<strong>as</strong>king <strong>of</strong> bitter APIs is a major challengeespecially <strong>for</strong> <strong>the</strong> development <strong>of</strong> orally administered dosage <strong>for</strong>ms in pharmaceuticalindustry [1] . In reality, most or many <strong>of</strong> <strong>the</strong> active pharmaceutical substances have ei<strong>the</strong>r anunple<strong>as</strong>ant t<strong>as</strong>te, such <strong>as</strong> bitterness, sourness or saltiness. Some <strong>of</strong> <strong>the</strong>m may <strong>of</strong>ten cause anirritating mouth feeling, including metallic and/or spicy t<strong>as</strong>te or <strong>as</strong>tringency. For <strong>the</strong>sere<strong>as</strong>ons, <strong>the</strong> need <strong>for</strong> a ple<strong>as</strong>ant t<strong>as</strong>te becomes a key <strong>as</strong>pect <strong>for</strong> patient palatability [2] . T<strong>as</strong>tem<strong>as</strong>king <strong>of</strong> various bitter active ingredients can be carried out using various <strong>technique</strong>sdepending on <strong>the</strong> type <strong>of</strong> APIs and <strong>the</strong> type <strong>of</strong> <strong>for</strong>mulation [3] .Currently, various t<strong>as</strong>te m<strong>as</strong>king methods are available. The most commonly usedconventional methods are film coating [4] and adding sugars, flavours or sweeteners[3]which are <strong>of</strong>ten limited due to regulatory requirements. Freeze-drying[1] , microencapsulation [5, 6] , fluidized bed coating [1] , high shear mixing [7] , supercritical fluids[8, 9]and spay drying [10] have been reported to be used <strong>as</strong> successful <strong>technique</strong>s <strong>for</strong> <strong>the</strong>purposes <strong>of</strong> t<strong>as</strong>te-m<strong>as</strong>king various bitter active subtances. In addition to <strong>the</strong> a<strong>for</strong>e mentionedconventional methods, different advanced and chemical t<strong>as</strong>te m<strong>as</strong>king approaches such <strong>as</strong>drug complexation by cyclodextrines [11, 12] , ion exchange resins [13] , prodrugs and differentsalt <strong>for</strong>mations [14] have been reported in <strong>the</strong> literature. Similarly, HME w<strong>as</strong> introduced <strong>as</strong>useful tool to produce polymeric extrudates with t<strong>as</strong>te m<strong>as</strong>king properties in a continuousprocess [15] . Different polymeric systems have already been implemented <strong>for</strong> t<strong>as</strong>te m<strong>as</strong>kingpurposes via <strong>the</strong> <strong>hot</strong>-<strong>melt</strong> <strong>extrusion</strong> (HME) processing and have been proved effective t<strong>as</strong>tem<strong>as</strong>kingapproach by applying polymeric coating layer that creates a physical barrier around<strong>the</strong> drug.Gryckze et al. (2011) successfully claimed t<strong>as</strong>te m<strong>as</strong>king <strong>of</strong> ibupr<strong>of</strong>en w<strong>as</strong> achievedthrough intermolecular <strong>for</strong>ces (e.g. hydrogen bonding) between <strong>the</strong> active substance and <strong>the</strong>polymer matrix by processing oppositely charged compounds [2] . Later, similar results wereobserved by Maniruzzaman et al. (2012) where <strong>the</strong> authors successfully managed to m<strong>as</strong>k <strong>the</strong>bitterness <strong>of</strong> paracetamol by applying <strong>the</strong> same mechanism [1] . In addition, solid dispersionswhere <strong>the</strong> drug is molecularly dispersed within <strong>the</strong> polymer matrix have shown effectivem<strong>as</strong>king <strong>of</strong> <strong>the</strong> drug‘s unple<strong>as</strong>ant t<strong>as</strong>te. Successful t<strong>as</strong>te m<strong>as</strong>king requires development <strong>of</strong>85 | P a g e